Stay updated on Sabatolimab in HMA for Higher Risk MDS Clinical Trial

Sign up to get notified when there's something new on the Sabatolimab in HMA for Higher Risk MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sabatolimab in HMA for Higher Risk MDS Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The history now includes a new revision entry for v3.5.4 and removes the previous v3.5.3. This updates the page's revision log to reflect the latest version.
    Difference
    0.1%
    Check dated 2026-05-15T04:17:32.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision label on the page changed from v3.5.2 to v3.5.3, indicating a new release of the site. This metadata update does not alter the study record content or how the data is displayed.
    Difference
    0.1%
    Check dated 2026-04-30T16:36:54.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    A new revision entry v3.5.2 is added and an older revision v3.5.0 is removed.
    Difference
    0.1%
    Check dated 2026-04-16T10:56:57.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added and revision v3.4.3 was removed from the Record History.
    Difference
    0.1%
    Check dated 2026-03-18T18:19:20.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Added a new revision entry v3.4.3 and removed the previous entry v3.4.2 from the record history.
    Difference
    0.1%
    Check dated 2026-03-11T14:44:54.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.2) was added to the history. The deletions include a funding notice and the prior revision (v3.4.1).
    Difference
    0.6%
    Check dated 2026-02-11T01:54:38.000Z thumbnail image

Stay in the know with updates to Sabatolimab in HMA for Higher Risk MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sabatolimab in HMA for Higher Risk MDS Clinical Trial page.